Therapeutic Occupancy Time [Regulatives / Guidelines]

posted by heritage – India, 2018-02-18 08:19 (3052 d 10:19 ago) – Posting: # 18432
Views: 4,937

Hi Helmut

Thank you for your reply

I need to learn three points

1. What should be design and patient population of the study? I found many studies on clinical trials.gov wherein patient was taken.

Can you advice any good articles to read wherein healthy were taken

2. T>MIC study can waive need to do clinical trial?

3. Is there any regulatory guidance available for T>MIC stud?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
366 visitors (0 registered, 366 guests [including 19 identified bots]).
Forum time: 19:39 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5